The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,379,961 Cooperative Agreement under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" program (CFDA 93.376) to Living Beyond Breast Cancer, a non-profit organization. The five-year award, running from September 30, 2024 to September 29, 2029, will support comprehensive services and resources for young breast cancer survivors and metastatic breast cancer...
The Centers for Disease Control and Prevention (CDC) awarded a $460,000 Cooperative Agreement under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) program to the National Association of Chronic Disease Directors, Inc. (NACDD). The five-year award, effective from September 30, 2024 to September 29, 2029, will support initiatives to increase support for caregivers and families of young breast cancer survivors and...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $460,000 Cooperative Agreement under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) program to the Young Survival Coalition, Inc. The five-year award period runs from September 30, 2024 to September 29, 2029. The funding aims to increase support for caregivers and families, raise awareness of clinical trials, and improve quality of life for young...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $460,000 Cooperative Agreement under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) federal grant program. The 5-year grant, with a performance period from September 30, 2024 to September 29, 2029, is provided to Weill Medical College of Cornell University to support comprehensive services for young breast cancer survivors and those with metastatic...
The Cooperative Agreement award of $460,000.00 was provided by the Centers for Disease Control and Prevention (CDC) under the federal grant program titled "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376). The award supports Sharsheret, a non-profit organization, in delivering products and services aimed at increasing support for caregivers and families of young breast cancer survivors and metastatic breast cancer...
The U.S. Centers for Disease Control and Prevention awarded a $460,000 Cooperative Agreement under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) federal grant program to the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, Massachusetts. The five-year award, spanning September 30, 2024 to September 29, 2029, will support DFCI's efforts to increase support for caregivers and families of young breast cancer...
This $920,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) program aims to provide comprehensive support for young breast cancer survivors and metastatic breast cancer patients. The award will fund interventions to increase support for caregivers and families, raise awareness of clinical trials, and improve quality of life...
The University of Illinois was awarded a $459,993 Cooperative Agreement under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) program by the Centers for Disease Control and Prevention. The five-year grant, awarded on September 30, 2024, will support initiatives to increase support for caregivers and families of young breast cancer survivors and metastatic breast cancer patients, raise awareness of clinical trials,...
This Cooperative Agreement award in the amount of $460,000.00 was granted by the Centers for Disease Control and Prevention (CDC) under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) program. The award will support the recipient organization, Force-Facing Our Risk Of Cancer Empowered, Inc., in delivering comprehensive services to young breast cancer survivors and metastatic breast cancer patients in Florida. Key...
This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under CFDA 93.376 "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" provides $433,375.00 in funding to Adelphi University for a 5-year project period from September 30, 2024 to September 29, 2029. The project aims to increase support for caregivers and families of young breast cancer survivors and metastatic breast cancer patients,...